OR WAIT null SECS
January 27, 2011
Novartis Acquires Genoptix; Lilly Exec Becomes Savient CEO; and More.
January 20, 2011
Merck Teams with Parexel; Roche CFO to Retire; and More
January 07, 2011
During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market.
Orally disintegrating tablets (ODTs) are growing in popularity and their market value could exceed $13 billion in sales by 2015, based on current global growth trends.
Biologics are large molecular weight molecules primarily formulated for parenteral administration; however, there are some smaller biomolecules that have been formulated for oral use.
January 06, 2011
Gilead Sciences to Acquire Arresto Biosciences; Sartorius Appoints Head of Lab Business; and More.
January 02, 2011
The authors conducted an experiment to determine the type of extrusion that provides the best productivity and pellet quality. This article contains online bonus material.
Capable of great works, pharma as a whole still yields to the lesser angels of its nature.
Developments in RNAi, monoclonal antibodies, and more are boosting the biotech marketplace.
The manufacture of orally dissolving films is done by various methods such as solvent casting, hot-melt extrusion, semisolid casting, solid-dispersion extrusion, and rolling. The authors discuss these methods and the various parameters in which dissolving films are evaluated.